Assessment of antithrombotic therapy before nerve or neuraxial block using thromboelastography

Assessment of antithrombotic therapy before nerve or neuraxial block using thromboelastography - Assessment of antithrombotic therapy before nerve or neuraxial block using thromboelastography

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040140

Enrollment

300

Registered

2020-04-13

Start date

2020-01-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Administration or cessation of antithrombotic therapy that necessitated nerve or neuraxial block to reduce perioperative surgical pain.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Administration or cessation of antithrombotic therapy that necessitated nerve or neuraxial block to reduce perioperative surgical pain.

Exclusion criteria

Exclusion criteria: hematologic disease

Design outcomes

Primary

Measure	Time frame
Reaction time, angle, kinetics, maximum amplitude, and lysis 30 min in each thromboelastography.	—

Secondary

Measure	Time frame
activated clotting time and morbidity.	—

Countries

Japan

Contacts

Public ContactHirotsugu Kanda

Asahikawa Medical University Department of Anesthesiology and Critical Care Medicine

hirotsugukanda0629@gmail.com0166682583

Outcome results